Abattis Financial Statements From 2010 to 2025
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Check Abattis Bioceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abattis Bioceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Abattis financial statements analysis is a perfect complement when working with Abattis Bioceuticals Valuation or Volatility modules.
Abattis |
Abattis Bioceuticals Corp Company Shares Outstanding Analysis
Abattis Bioceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Abattis Bioceuticals Shares Outstanding | 477.8 M |
Most of Abattis Bioceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abattis Bioceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Abattis Bioceuticals Corp has 477.8 M of shares currently outstending. This is 164.66% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 16.44% higher than that of the company.
Abattis Bioceuticals Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abattis Bioceuticals's current stock value. Our valuation model uses many indicators to compare Abattis Bioceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abattis Bioceuticals competition to find correlations between indicators driving Abattis Bioceuticals's intrinsic value. More Info.Abattis Bioceuticals Corp is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abattis Bioceuticals' earnings, one of the primary drivers of an investment's value.About Abattis Bioceuticals Financial Statements
Abattis Bioceuticals stakeholders use historical fundamental indicators, such as Abattis Bioceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Abattis Bioceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Abattis Bioceuticals' assets and liabilities are reflected in the revenues and expenses on Abattis Bioceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Abattis Bioceuticals Corp. Please read more on our technical analysis and fundamental analysis pages.
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. ABATTIS BIOCEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Abattis Pink Sheet
Abattis Bioceuticals financial ratios help investors to determine whether Abattis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abattis with respect to the benefits of owning Abattis Bioceuticals security.